1. National Guidelines for the Clinical Management of HIV Infection in Children and Adults. AIDS Division, Department of Communicable Disease Control. Ministry of Public Health, Nonthaburi Thailand.
2. van Leth F, Phanuphak P, Ruxrungtham K et al. Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet2004; 363: 1253–63.
3. Kappelhoff BS, van Leth F, MacGregor TR et al. Nevirapine and efavirenz pharmacokinetics and covariate analysis in the 2NN study. Antivir Ther2005; 10: 145–55.
4. Boyd M, Duncombe C, Ruxrungtham K et al. Indinavir TID vs indinavir/ritonavir BID in combination with AZT/3TC for HIV infection in nucleoside pretreated patients: HIV-NAT 005 76-week follow up. In: Programs and Abstracts of the Ninth Conference on Retroviruses and Opportunistic Infections, Seattle, WA, USA, 2002. Abstract 422-W. Foundation for Retrovirology and Human Health, Alexandria, VA, USA.
5. Burger D, Boyd M, Duncombe C et al. Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients. J Antimicrob Chemother2003; 51: 1231–8.